Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery

In Vivo · Published 2026-06-30 · DOI 10.21873/invivo.14380

Free full text

Authors (6)

NOBUKI FURUBAYASHI, TAKEHITO KOJIMA, YASUHIRO NAKANO, AKARI KATAOKA, MOTONOBU NAKAMURA, TAKAHITO NEGISHI

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

FURUBAYASHI, N., KOJIMA, T., NAKANO, Y., et al. (2026). Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery. In Vivo. https://doi.org/10.21873/invivo.14380

Related articles